Connor, Clark & Lunn Investment Management (CC&L)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $673K | Sell |
|
|||||
|
2025
Q1 | $23.7M | Buy |
|
|||||
|
2024
Q4 | $17.1M | Buy |
|
|||||
|
2024
Q3 | $3.56M | Sell |
|
|||||
|
2024
Q2 | $66.7M | Buy |
|
|||||
|
2024
Q1 | $56.8M | Buy |
|
|||||
|
2023
Q4 | $6.96M | Buy |
|
|||||
|
2023
Q3 | $3.53M | Buy |
|
|||||
|
2023
Q2 | $2.13M | Sell |
|
|||||
|
2023
Q1 | $15.1M | Buy |
|
|||||
|
2022
Q4 | $3.91M | Buy |
|
|||||
|
2022
Q3 | $2.55M | Buy |
|
|||||
|
2022
Q2 | $1.76M | Sell |
|
|||||
|
2022
Q1 | $21.6M | Buy |
|
|||||
|
2021
Q4 | $10.7M | Buy |
|
|||||
|
2021
Q3 | $4.67M | Sell |
|
|||||
|
2021
Q2 | $5.08M | Buy |
|
|||||
|
2021
Q1 | $4.42M | Sell |
|
|||||
|
2020
Q4 | $4.85M | Buy |
|
|||||
|
2020
Q3 | $3.02M | Sell |
|
|||||
|
2020
Q2 | $6.02M | Buy |
|
|||||
|
2020
Q1 | $4.13M | Sell |
|
|||||
|
2019
Q4 | $3.82M | Buy |
|
|||||
|
2019
Q3 | $3.61M | Sell |
|
|||||
|
2019
Q2 | $4.88M | Sell |
|
|||||
|
2019
Q1 | $6.78M | Buy |
|
|||||
|
2018
Q4 | $3.73M | Sell |
|
|||||
|
2018
Q3 | $8.06M | Buy |
|
|||||
|
2018
Q2 | $4.63M | Sell |
|
|||||
|
2018
Q1 | $4.95M | Sell |
|
|||||
|
2017
Q4 | $11.9M | Buy |
|
|||||
|
2017
Q3 | $12.1M | Sell |
|
|||||
|
2017
Q2 | $15.1M | Buy |
|
|||||
|
2017
Q1 | $4.33M | Sell |
|
|||||
|
2016
Q4 | $4.58M | Buy |
|
|||||
|
2016
Q3 | $5.02M | Sell |
|
|||||
|
2016
Q2 | $21.9M | Sell |
|
|||||
|
2016
Q1 | $30M | Sell |
|
|||||
|
2015
Q4 | $46M | Sell |
|
|||||
|
2015
Q3 | $59M | Buy |
|
|||||
|
2015
Q2 | $34.2M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $17.2M | Sell |
|
|||||
|
2014
Q2 | $25.6M | Buy |
|
|||||
|
2014
Q1 | – | Sell |
|
|||||
|
2013
Q4 | $20.6M | Buy |
|
|||||
|
2013
Q3 | $5.65M | Sell |
|
|||||
|
2013
Q2 | $5.69M | Buy |
|